|
EspAddText
EspRemoveText
|
Toward a Dementia Strategy for Canada: CMA Submission to the House of Commons Standing Committee on Finance
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Presentation to the House of Commons Standing Committee on Environment and Sustainable Development
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
CMA Submission: The need for health infrastructure in Canada
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Canadian Medical Association Submission on Bill S-209, An Act to Amend the Criminal Code (prize fights)
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Canadian Medical Association Submission on Motion 315 (Income Inequality)
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Canadian Medical Association Submission on Bill C-462 Disability Tax Credit Promoters Restrictions Act
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Submission on Bill C-462 Disability Tax Credit Promoters Restrictions Act. Submitted to the House of Commons Standing Committee on Finance
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Healthier Generations for a Prosperous Economy: Canadian Medical Association 2013-2014 pre-budget consultation submission to the Standing Committee on Finance
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
A new vision for health care in Canada: Addressing the needs of an aging population. 2016 pre-budget submission to the Minister of Finance
|
Parliamentary submission
|
2016
|
|
EspAddText
EspRemoveText
|
Consultation on the prescription drug list: Naloxone
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Small business perspectives of physician medical practices in Canada
|
Parliamentary submission
|
2016
|
|
EspAddText
EspRemoveText
|
Reducing barriers to physician mobility and for a more uniformed healthcare system in Canada
|
Parliamentary submission
|
2016
|
|
EspAddText
EspRemoveText
|
Joint Canadian Medical Association & Canadian Psychiatric Association Policy - Access to mental health care
|
Policy document
|
2016
|
|
EspAddText
EspRemoveText
|
National pharmacare in Canada: Getting there from here
|
Parliamentary submission
|
2016
|
|
EspAddText
EspRemoveText
|
Health Canada’s Consultation on “Plain and Standardized Packaging”
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Legalization, regulation and restriction of access to marijuana
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Avoiding negative consequences to health care delivery from federal taxation policy
|
Response to consultation
|
2016
|